Phase 1 Advanced Lung Cancer Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Metastatic Breast CancerAdvanced Breast CancerMetastatic Lung Cancer+6 more
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 enrolled31 locationsNCT06625775
Recruiting
Phase 1Phase 2
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Advanced Lung Cancer
BioNTech SE594 enrolled45 locationsNCT06892548
Recruiting
Phase 1Phase 2
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd300 enrolled1 locationNCT07229599
Recruiting
Phase 1
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06945523
Recruiting
Phase 1
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06992583
Recruiting
Phase 1
Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06903117
Recruiting
Phase 1
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd48 enrolled1 locationNCT06768151